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Abstract 
Purpose: To identify and quantify possible errors in handwritten outpatient prescriptions in relation to 
adherence to standard guidelines on the layout and content of prescriptions. 
Method: A sample of 200 handwritten outpatient prescriptions were collected from two pharmacies 
located in a sub-urban (Aluthgama) and an urban (Kandy) area in Sri Lanka. Data were extracted using 
a pilot-tested questionnaire and the legibility of the prescription was assessed by three independent 
investigators. The results from the suburban area were compared with those from the urban area. 
Results: Based on the layout of the prescription, the presence of patient information was unsatisfactory. 
Patient name and age were present in less than half of the prescriptions. However, prescriber 
information except registration number was present in more than 75 % of the prescriptions. Date of 
consultation was present in > 81.5 % of the prescriptions. Non-standard abbreviations were used in 36.5 
% of the prescriptions while incomplete units were observed in 51 % of the prescriptions. Nearly half of 
the prescriptions from both urban and suburban locations were illegible. Occurrence of prescriber 
details was a significantly different between Aluthgama and Kandy. 
Conclusion: Prescription errors are common in outpatient settings of Aluthgama and Kandy areas in 
Sri Lanka. Standardized prescription writing process in relation to layout, use of abbreviations, and units 
and legibility, is proposed as a potential solution to overcome this problem. 
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United States Pharmacopoeia defines 
medication errors as any preventable event that 
may cause or lead to an inappropriate 
medication use or patient harm while the 
medication is in control of the healthcare 
professional, patient or consumer [1]. Medication 
errors can occur in all stages of the medication 
process: prescribing, dispensing, administration, 
monitoring and documentation [2,3]. 
  
A study in USA stated that the medication errors 
are the eighth most frequent cause of death in 
USA which was more frequent than car 
accidents, breast cancers or AIDS [4]. 
Medication errors increase health care cost, 
increase unnecessary diagnostic tests and 
treatments, prolong hospital stay, decrease 
confidence of patients in health care system and 
increase the risk of patient death or serious 
patient morbidity almost two-fold [5-7]. 
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Prescription error is a type of medication error 
which is defined as an error in prescribing 
decision or prescription writing process, where 
there is an unintentional significant reduction in 
the probability of treatment being timely and 
effective or increase in the risk of harm when 
compared with generally accepted practice [8]. 
Errors in prescribing decision can be subdivided 
as inappropriate prescription and pharmaceutical 
issues.  
 
Errors in prescription writing process can be 
subdivided into failure to communicate essential 
information and transcription errors [8]. 
Prescription writing stage is the most common 
stage of errors (99.12 %) according to a study 
carried out in Indonesia on outpatients of a 
government hospital [9]. Another prospective 
observational study done in United Kingdom 
showed that 10 % of prescriptions in hospitals 
contained errors [10]. 
 
This current study was conducted to assess the 
possible errors in outpatient handwritten 
prescriptions in relation to adherence to standard 
guidelines on layout and content of the 
prescriptions; use of abbreviations for drug 
name, use of non-standard abbreviations for 
directions for drug, use of incomplete units, use 







Prescription errors were assessed using 
handwritten prescriptions. A convenient sample 
of two hundred (200) prescriptions were collected 
from two community pharmacies situated in two 
provinces, Western province and Central 
province during 4 months period from April 2013 
to August 2013. One pharmacy is situated in 
Aluthgama which is a suburban area in Kalutara 
district of Western Province and the other one is 
in Kandy, an urban area of Central Province. 





Ethical approval was obtained from Ethical 
Review Committee of Faculty of Allied Health 
Sciences, University of Peradeniya, Peradeniya, 
Sri Lanka before commencing the study. Photos 
(snap shots) of the prescriptions without the 
information revealing patient and prescriber 
identities were taken after getting the verbal 




As the first part of the study, errors in the layout 
of the prescriptions were assessed on the basis 
of the presence or otherwise of patient’s 
information (patient name, age and gender), 
prescriber’s information (name of the prescriber, 
contact detail, qualifications, registration number, 
and signature) and date of consultation. If the full 
name of the patient or the name with initials was 
present, that was categorized as the presence of 
the name or if half of the name was present it 
was categorized as incomplete name or if the 
name was not present it was categorized as 
absence of the patient name. If the age was 
written with both number and year or months 
(e.g., 57 years or 5 months), that was 
categorized as the presence of age, if one 
component was missing it was an incomplete 
age and if the age was not mentioned in the 
prescription it was categorized as absent of age. 
If the gender of the patient was mentioned it was 
categorized as presence of gender or otherwise.  
 
Gender is considered present for the purpose of 
this study if it is mentioned directly or more 
commonly by the title used in front of the 
patient’s name e.g. Mr., Miss, Mrs.  
 
Prescriber’s name, contact details, qualification, 
registration number and signature were 
evaluated for their presence or absence. Full 
name or name with initials was only categorized 
as presence of the prescriber’s name. If part of 
the name was present, it was categorized as 
incomplete and if the name was not present it 
was categorized as absence of the prescriber’s 
name. If the prescriber’s address or telephone 
number or fax number or email was given it was 
categorized as presence of contact details and at 
least one from above was not present it was 
categorized as absence of contact details. If the 
qualification of the prescriber was present, it was 
noted down as the prescriber is a specialist or a 
general practitioner for further data evaluations.  
 
Only the Postgraduate Institute of Medicines 
accredited specialist was considered as a 
specialist. Presence or absences of the signature 
of the prescriber and the registration number 
were evaluated. Date of consultation was 
categorized as presence only if the date contains 
day, month and year. If any component was 
missing it was an incomplete date. If the date 
was missing it was categorized as absence of 
the date. 
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The content of the prescription was assessed as 
the second part of the study. Usage of non-
standard abbreviations was evaluated with the 
help of the abbreviation list that is mentioned in 
the British National Formulary [11]. Any 
abbreviation that is not in that list was 
categorized as a non-standard abbreviation. 
Those used non-standard abbreviations were 
noted down. If units were written as “µg, ng, u, 
tsp, or tab” or if there was only numbers without 
any unit for the strength of the drug, they were 
categorized as incomplete units. Presence or 
absences of those were evaluated and if they 
were present, that abbreviations were noted 
down. Presence or absences of avoidable 
decimal points were evaluated. 
 
As the third part of the study, legibility of the 
prescription was evaluated by three final year 
B.Pharm students minimizing the error that can 
occur by not knowing the trade names of the 
drugs by one person and minimizing being bias 
by being familiar with one or two prescribers’ 
handwriting. 
 
Each medicine mentioned in the prescription was 
looked separately for name, dose, frequency and 
duration. If all 4 categories could clearly be 
copied, it was labelled as “clear”, if all 4 
categories could be copied with difficulty, it was 
labelled as “clear with effort” and if any of the 4 
categories could not be copied, it was labelled as 
“not clear”. Then all three assessors’ remarks 
were taken and gave the final categorization 
using the majority’s view (2/3). And if > 75 of 
individual components were either clear or clear 
with difficulty the prescription was labeled as 
legible and if not illegible. While assessing the 
legibility of the prescriptions, clarifications of 
brand names of the drugs were done using the 
official web site of Cosmetic Drugs and Devices 





Microsoft Excel (2010) and Minitab 16 software 
were used to analyze all the data. Comparisons 
were made between the variables of the two 
study locations and between professionals 
involved in prescription writing (specialists and 
general practitioners) using Chi square test. The 
results of incomplete and absent of name of the 
patient, age, name of the prescriber and date of 
consultation were combined in the Chi square 





One hundred handwritten outpatient 
prescriptions from each study location were 
reviewed for errors in the layout and the content 
of the prescriptions. Findings related to the 
studied attributes are shown in Table 1. 
 
According to the Table 1, name of the patient 
was present in 75 (37.5 %) of the prescriptions 
and age was present in 92 (46 %) of the 
prescriptions. Name of the prescriber was found 
in 181 (90.5 %) while 148 (74 %) of the 
prescriptions had contact details. We found 170 
(85 %) and 150 (75 %) of prescriptions with the 
qualifications and signature of the prescriber 
respectively. Date of consultation was present in 
163 (81.5 %) prescriptions. 
 
There were 73 (36.5 %) and 102 (51 %) of 
prescriptions with non-standard abbreviations 
and incomplete units. Any of the prescription did 
not include any avoidable decimal point. Among 
all the prescriptions, we found 99 (49.5 %) legible 
prescriptions. 
 
Table 1: Percentage occurrence of components of the prescriptions and p values obtained from chi square test 
for two study locations 
 
Attribute Frequency (%) Aluthgama Kandy P-value 
Presence of name of the patient 75 (37.5%) 36 39 0.661 
Presence of age 92 (46%) 49 43 0.395 
Presence of gender  155 (77.5%) 70 85 0.011* 
Presence of name of the prescriber 181 (90.5%) 84 97 0.002* 
Presence of contact details  148 (74%) 64 84 0.001* 
Presence of qualification 170 (85%) 73 97 0.000* 
Presence of registration number 32 (16%) 24 8 0.002* 
Presence of signature 150 (75%) 62 88 0.000* 
Presence of date of consultation 163 (81.5%) 75 88 0.018* 
Presence of non-standard abbreviations 73 (36.5%) 35 38 0.659 
Presence of incomplete units 102 (51%) 53 49 0.572 
Presence of avoidable decimal points 0 (0%) 0 0  Legible prescriptions 99 (49.5%) 48 51 0.671 
*P < 0.05 is considered statistically significant 
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Table 2: P-values obtained from Chi square test for specialists and general practitioners 
 
Attribute Specialist General practitioner P-value 
Presence of name of the patient 42 12 0.000* 
Presence of age 51 47 0.572 
Presence of gender  79 76 0.611 
Presence of name of the prescriber 100 100  Presence of contact details  82 82 1.000 
Presence of registration number 10 76 0.000* 
Presence of signature 82 71 0.067 
Presence of date of consultation 89 65 0.000* 
Presence of non-standard abbreviations 37 24 0.046* 
Presence of incomplete units 51 47 0.572 
Presence of avoidable decimal points 0 0  Legible prescriptions 49 65 0.022* 
*P < 0.05 is considered as statistically significant 
 
Name of the patient and age was either absent 
or incomplete in more than 50 % of the 
prescriptions while all the prescriber details 
except registration number was present in more 
than 60 % of the prescriptions in both districts. 
Nearly half of the prescriptions from Aluthgama 
and Kandy had incomplete units (Table 1). 
 
Comparison of results between two study 
locations revealed that results for half of the 
criteria such as presence of gender of the 
patient, information of the prescriber and date of 
consultation are significantly different between 
those two sites. Resulted chi square values and 
p values are tabulated in Table 1. 
 
Results of five studied attributes such as name of 
the patient, date of consultation, non-standard 
abbreviations and legibility of the prescriptions 
were significantly different between prescriptions 
from specialists and general practitioners. 
Resulted chi square values and p values are 




At the beginning of this research, it was assumed 
that results from these two locations will be 
different from each other as they are suburban 
and urban areas, respectively, where state 
hospital facilities differ. However, for half of the 
criteria reviewed, both had approximately equal 
percentage of errors. Though there is a 
difference in hospital facilities in these two areas, 
private consultation centers fill this gap. This may 
be the reason for having this result.  
 
More than half of the prescriptions from two 
locations (Table 1) only had a surname or one 
part of the name of the patient without at least 
initials as the name which can lead to confusion 
of the pharmacist and also the patients. As these 
are outpatient prescriptions which are given to 
the patient’s hand and confusions can happen at 
home having same surname for the family 
members. In a study done in India, patient name 
was absent in 58.5 % of the prescriptions [15] 
which is similar to the results of this study but a 
study done in Saudi Arabia reported 94.6 % 
prescriptions with patient’s name [16]. Reported 
results from an Indonesian study of the presence 
of age (52.4 %) which is essential for the 
clarification of the dose was approximately 
similar to the results of this study (Table 2) [9]. 
But similar to the results of the presence of 
patient’s name, same Saudi Arabian study 
reported 77.2 % prescriptions with patient’s age 
[16]. The reasons for not having complete 
patient’s information in prescriptions from Sri 
Lanka, India and Indonesia and having that 
information in prescriptions from Saudi Arabia 
are probably due to the busy working 
environment where a prescriber cannot attend to 
one patient for a longer time and also not having 
ideal formats for prescriptions.  
 
Information of the prescriber such as prescriber’s 
name, contact details, qualifications and 
signature were present in more than half of the 
prescriptions from both places (Table 1). This is 
because of the usage of rubber seal by the 
prescribers. But this rubber seal was not clear in 
most of the prescriptions. Therefore even though 
contact details are available in the prescription 
pharmacist may not be able to contact 
prescribers when it is necessary. 
 
The reported results for the presence of 
prescriber’s information from the Indian study on 
irrational drug use in India were similar to the 
results that were revealed by this study [15]. But 
in the study done in Saudi Arabia, there were 
more than 80 % prescriptions with prescriber’s 
name and signature [16]. 
 
Date of consultation was present in majority of 
the prescriptions of both locations (Table 1). It 
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was approximately similar to the results found 
from the Indian study where there were 84.5 % 
prescriptions with date of consultation [15]. But 
surprisingly prescriptions that were reviewed in 
the Saudi Arabian study had only 35.7 % 
prescriptions with the date [16]. This may be due 
to the difference in the definition of the criteria. 
 
There were two types of non-standard 
abbreviations in these reviewed prescriptions. 
They were abbreviations in instructions for drug 
administration and abbreviation for drug name. 
Some of the non-standard abbreviations in 
instructions for drug administration were tsp, tab, 
d, m, n and H and abbreviations for drug names 
were HCQ, PCM and HCT. These results which 
are shown in Table 1 are similar to a Sudan 
study where there were 37.2 % of prescriptions 
with non-standard abbreviations [17]. Any of 
these abbreviations are not standard and they 
can lead to medication errors. Reason for using 
abbreviations for drug names can be the scarcity 
of time and other abbreviations such as tab, m 
and n may be mostly writing as a habit of the 
prescriber [14,18]. 
 
The occurrence of incomplete units is higher than 
the occurrence of non-standard abbreviations 
(Table 1). Mostly apparent incomplete units were 
µg, u, tab and tsp. There were prescriptions with 
no unit for the strength of the drug and also 
prescriptions with number of tablets instead of 
the strength of the drug. These were also taken 
as incomplete units.  These types of incomplete 
units were written due to the same reasons for 
writing nonstandard abbreviations. Sometimes 
negligence of prescriber may lead to 
prescriptions with no units or write in number of 
tablets [18]. In a study it is said prescribers leave 
the strength, dose and quantity of the drugs to 
decide by the pharmacist [17]. Prescriptions 
without clear and complete instructions to the 
pharmacist and to the patient can lead to 
difficulty in understanding the dosage regimen 
and adverse effects. 
 
Nearly half of the prescriptions from both 
locations were illegible as shown in Table 1. 
Studies done on assessing legibility of the 
prescription have different definitions for the 
legibility [19,20]. Therefore results may be 
difficult to compare. A published report from 
Switzerland states that, legibility was assessed 
depending on four criteria such as “good, 
moderate, bad and illegible’. They reported 4 % 
prescriptions which are illegible [21]. But the 
study done in Saudi Arabia adopted a method to 
assess legibility which is similar with our 
research and found 64.3 % prescriptions which 
were not clear [16].  
Most of the illegible prescriptions which were 
reviewed had legible drug name while duration 
and strengths were illegible. It seems like 
prescribers do not pay attention to the duration 
and strength of the drug. This was highlighted in 
a study done on inpatient prescriptions in the 
United Kingdom where it was said prescribers 
write only the drug name and left other details 
such as duration, dose, route and form to 
complete by house officers [8]. It seems similar 
to the situation here where prescribers expect to 
predict those details by pharmacists. Some 
prescriptions had completely illegible drug names 
and some had drug names only with legible first 
letters. This may be due to the fact that 
prescribers have forgotten full names especially 
the brand names. 
 
The illegibility will be less if these were assessed 
using experienced pharmacists or pharmacists 
from same areas where prescriptions were 
collected. Because they are more familiar with 
the brand names and familiar with the particular 
prescriber’s hand writing than final year 
undergraduate pharmacy students. But here we 
assumed, a prescription should be legible 
enough to read by a final year B.Pharm student 
rather than guessing the drugs in the 
prescriptions. Another reason for having a high 
number of illegible prescriptions could be the fact 
that illegibility of any part from name, dose, 
frequency and duration of the drug was assessed 
as illegibility of complete drug.  
 
In the comparison of the two study locations it 
was revealed that prescribers details are missing 
significantly more in prescriptions from suburban 
area compared to the urban area. This might be 
a regional difference where prescribers are not 
much concerned about this as there are fewer 
prescribers. Similarly by comparing specialist 
and general practitioners, it was revealed that 
specialists seem to write more name and date of 
consultation. This is probably because these are 
written by someone else that is appointed for that 
task. But legibility of the prescriptions was better 
with non-specialists and non-standard 
abbreviations were used more by specialists 
compared to general practitioners.  The 
registration number of the prescriber was missing 
more in prescriptions from specialists. This is 
probably because they think it is not important in 
view of their specialist qualifications. 
 
Limitations of the study 
 
The study was conducted in only two 
communities in two locations, thus limiting the 
generalizability of the findings. Using one 
pharmacy in one study location may not be 
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representative of the whole area even though the 
two selected pharmacies were large pharmacies 





Several areas that need improvement to 
minimize medication errors are identified in this 
study and these include stating patient name and 
age, as well as legibility of prescriptions. Lack of 
standardization of prescription writing process in 
relation to layout, use of abbreviations and units 
and legibility may be the main reason for this 
unsatisfactory nature of the layout and content of 
prescriptions. Efforts should be made to enhance 
the awareness of prescribers, pharmacists and 
patients regarding prescription errors, and also to 
stress the necessity of writing prescriptions 
completely and legibly, preferably in printed form, 
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